home / stock / lixt / lixt news


LIXT News and Press, Lixte Biotechnology Holdings Inc. From 04/24/24

Stock Information

Company Name: Lixte Biotechnology Holdings Inc.
Stock Symbol: LIXT
Market: OTC

Menu

LIXT LIXT Quote LIXT Short LIXT News LIXT Articles LIXT Message Board
Get LIXT Alerts

News, Short Squeeze, Breakout and More Instantly...

LIXT - Mixed Shelf Filing Gives Micro Cap Delayed Boost

2024-04-24 17:14:01 ET A California-based %Biotech company is finding pretty serious success on Wednesday a day after the company filed a registration statement covering the potential sale of up to $50 million mixed shelf offering, which covered common shares, preferred shares, debt sec...

LIXT - MSTR, BIOR and ARBK among pre-market losers

2024-04-01 08:31:15 ET More on Pre-market losers & stocks. MicroStrategy Is A $1 Box Of Bitcoin Trading For $1.91 Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript MicroStrategy: A Bad Deal For Investors MicroStrategy among most squeezable ...

LIXT - US Companies Moving the Markets, Evening edition
Wed, Mar 27, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Nikola Corporation (NKLA) rose 11.7% to $0.9091 on volume of 189,265,043 shares iBio Inc. (IBIO) rose 192.2% to $3.36 on volume of 167,159,370 shares Verb Technology Company Inc. (VERB) rose 0.4% to $0.281 on volume of 126,638,529 sha...

LIXT - Biotech Steals The Mid-Week Show Following Pre-Clinical Data Announcement

2024-03-27 14:46:54 ET A California-based %Biotech company stirred things up on Wednesday after it was announced the publication of preclinical data on its lead clinical compound, LB-100. Traders couldn’t get their hands on shares of %LixteBiotechnology (NASDAQ: $LIXT), p...

LIXT - Lixte stock soars on preclinical data for lead drug LB-100

2024-03-27 14:43:15 ET More on Lixte Biotechnology Holdings, Inc. Financial information for Lixte Biotechnology Holdings, Inc. Read the full article on Seeking Alpha For further details see: Lixte stock soars on preclinical data for lead drug LB-100

LIXT - Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) Near Top of Volume Charts in Wednesday Trading

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) is one today's most active stocks by volume. So far today, approximately 22.95M shares of Lixte Biotechnology Holdings, Inc. have been exchanged, as compared to an average 30-day volume of 86,145 shares. Lixte Biotechnology Holdings, Inc. opera...

LIXT - iBio, ImmunityBio, Mesoblast among healthcare movers

2024-03-27 10:00:45 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...

LIXT - US Companies Moving the Markets, Morning edition
Wed, Mar 27, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 34.1% to $0.3754 on volume of 55,110,141 shares Gamida Cell Ltd. (GMDA) fell 82.7% to $0.0594 on volume of 50,587,982 shares iBio Inc. (IBIO) rose 111.3% to $2.43 on volume of 40,863,066 shares...

LIXT - NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE'S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES

LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE CURRENT LIXTE CLINICAL TRIALS PASADENA, CA, March 27, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company&...

LIXT - LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments

-- Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers -- PASADENA, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage ...

Previous 10 Next 10